SignaBlok awarded NIAAA / NIH SBIR Phase I grant to test new approach to treatment of alcoholic liver disease

SignaBlok > News > SignaBlok awarded NIAAA / NIH SBIR Phase I grant to test new approach to treatment of alcoholic liver disease

SignaBlok > News > SignaBlok awarded NIAAA / NIH SBIR Phase I grant to test new approach to treatment of alcoholic liver disease

SignaBlok awarded NIAAA / NIH SBIR Phase I grant to test new approach to treatment of alcoholic liver disease

Vera

View posts by Vera